United Biomedical, Inc. Product Analysis & Forecast - 2015

1
United Biomedical, Inc. Product Pipeline Review -
2015
Published on October - 2015
2
.
Report Overview
About United Biomedical, Inc. Product Pipeline
Review - 2015 Global Markets Directs, United
Biomedical Inc. Product Pipeline Review - 2015,
provides an overview of the United Biomedical
Inc. s pharmaceutical research and development
focus. This report provides comprehensive
information on the current therapeutic
developmental pipeline of United Biomedical Inc.
s, complete with comparative analysis at various
stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of
administration (RoA) and molecule type. It also
reviews latest updates, and featured news and
press releases, along with special features on
late-stage and discontinued projects. Global
Markets Directs report features investigational
drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is
built using data and information sourced from
Global Markets Directs proprietary databases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. Get
Full Details On http//www.researchbeam.com/unit
ed-biomedical-inc-product-pipeline-review-2015-mar
ket
3
.
Report Overview
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides
brief overview of United Biomedical Inc.
including business description, key information
and facts, and its locations and subsidiaries The
report reviews current pipeline of United
Biomedical Inc.s human therapeutic division and
enlists all their major and minor projects
4
.
Report Overview
The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones Special feature on
out-licensed and partnered product portfolio The
report summarizes all the dormant and
discontinued pipeline projects Latest company
statement Latest news and deals relating to the
United Biomedical Inc.s pipeline
products   Reasons to buy Evaluate United
Biomedical Inc.s strategic position with total
access to detailed information on its product
pipeline Assess the growth potential of United
Biomedical Inc. in its therapy areas of
focus Identify new drug targets and therapeutic
classes in the United Biomedical Inc.s RD
portfolio and develop key strategic initiatives
to reinforce pipeline in those areas Exploit
in-licensing opportunities by identifying windows
of opportunity to fill portfolio gaps
5
Report Overview

• Develop strategic initiatives by understanding
  the focus areas of United Biomedical Inc. and
  exploit collaboration and partnership
  opportunities
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by
  identifying the most promising pipeline of United
  Biomedical Inc.
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Explore the dormant and discontinued projects of
  United Biomedical Inc. and identify potential
  opportunities in those areas
• Avoid Intellectual Property Rights related issues

6
Table Of Contents
List of Tables 5List of Figures 5United
Biomedical Inc. Snapshot 6United Biomedical
Inc. Overview 6Key Information 6Key Facts
6United Biomedical Inc. - Research and
Development Overview 7Key Therapeutic Areas
7United Biomedical Inc. - Pipeline Review
10Pipeline Products by Stage of Development
10Pipeline Products - Monotherapy 11Pipeline
Products - Partnered Products 12Partnered
Products/Combination Treatment Modalities
13Pipeline Products - Out-Licensed Products 14
7
Table Of Contents
Out-Licensed Products/Combination Treatment
Modalities 15United Biomedical Inc. - Pipeline
Products Glance 16United Biomedical Inc. -
Clinical Stage Pipeline Products 16Phase II
Products/Combination Treatment Modalities
16Phase I Products/Combination Treatment
Modalities 17United Biomedical Inc. - Early
Stage Pipeline Products 18Preclinical
Products/Combination Treatment Modalities
18Discovery Products/Combination Treatment
Modalities 19
8
Table Of Contents
United Biomedical Inc. - Drug Profiles
20CV-9103 20Product Description 20Mechanism of
Action 20RD Progress 20 CV-9104 22Product
Description 22Mechanism of Action 22RD
Progress 22   Enquiry about this report _at_
http//www.researchbeam.com/united-biomedical-inc-
product-pipeline-review-2015-market/enquire-about-
report
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/united-biomedical-inc-
product-pipeline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] E-MAIL
sales_at_researchbeam.com